Home » Topics » BioWorld Science

BioWorld Science
RSS

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

FDA advisory committee to review rotavirus vaccine

Nov. 20, 1997

Nortran and Bridge Pharma to develop dermal anesthetics

Nov. 20, 1997

Life Medical Sciences: Q2 and nine-month 1997 highlights

Nov. 20, 1997

FDA advisory committee recommends approval of Prandin

Nov. 20, 1997

Matritech: Q3 1997 highlights

Nov. 20, 1997

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

Novartis' NK1 antagonist in clinical studies for pain

Nov. 20, 1997

GL-701 shows significant steroid-sparing effects in women with active SLE

Nov. 20, 1997

Synvisc introduced in U.S.

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...